This report attempts to provide a comprehensive summary of the relevant indicators of mental health and present a detailed analysis of the cost of psychiatric care, particularly highlighting the cost of mental health medications and dietary supplements in Ukraine. The study strives to shed light on the pharmaceutical aspect of providing care to people with mental health conditions in Ukraine. This report consciously presents data and analysis from the pre-COVID times in Ukraine as the COVID-19 pandemic significantly disrupted access to health care and medicines. Key results reveal that out-of-pocket costs of medicines used to treat mental disorders may exceed government spending on the entire psychiatric care network. The report provides a detailed review of the utilization and spending of (a) medicines mainly used in the treatment of people with mental disorders (neuroleptics, tranquilizers, antidepressants, and so on) and (b) medicines that can provisionally be used in the treatment of people with mental disorders (nootropics, hypnotics, antiepileptic medicines, and so on).